Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can adding mesh support to rectocele surgery boost results?

NCT ID NCT07777146

Disease control Sponsor: Cairo University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 20, 2026 · Last updated Aug 27, 2026 · Updated 3 times

Summary

This trial tests whether adding a mesh support to a standard surgery (STARR) helps people with a rectocele and excessive perineal descent who haven't improved with conservative care. Participants are randomly assigned to receive either STARR alone or STARR plus the mesh support. The main goal is to see if the combined approach better reduces obstructed defecation symptoms, with secondary checks on pain, complications, and sexual function.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Surgical procedures: STARR (stapled transanal rectal resection) alone or combined with transverse perineal support using a polypropylene mesh.
What this could lead to
If adding mesh support works better, it could offer a more effective surgical option for people with rectocele and excessive perineal descent, improving bowel symptoms and quality of life.
What could go wrong
This is a relatively small trial, and the added mesh procedure may not improve outcomes or could increase risks like infection or pain. Results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 64 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Sep 2026

An estimate. Start dates often move.

Expected to finish

Jan 2028

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adult patients complaining of obstructed defecation syndrome with anterior rectocele ≥ 3 cm associated with excessive perineal descent with failure of conservative management. Exclusion Criteria: * Patients with Slow-transit constipation * Patients with anterior rectocele of \< 3 cm * Patients with complete external rectal prolapse * Evidence of colorectal carcinoma or Inflammatory bowel disease ( IBD) * Inability for lifestyle change postoperatively * Patients with fecal incontinence * Previous surgeries for anterior rectocele

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Perineal descent are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

perineocele Rectocele

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Perineal descent Rectocele

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Faculty of medicine, Cairo University

    Cairo, Al-Manial, Cairo, Egypt, Egypt, 11451, Egypt

More trials for these conditions

Other studies related to the condition(s) this trial covers.